Optigenex Inc. Announces New Business to Business Web Site to Target Select Marketing and Manufacturing Companies in

NEW YORK, NY, Nov 03 (MARKET WIRE) --
Optigenex Inc. (PINKSHEETS: OPGX) has unveiled a new information web page
www.optigenex.com designed to connect with prospective corporate
customers and partners in the wellness and personal care industries.

The new Optigenex web site replaces the company's earlier
consumer-oriented web page; the new site showcases the company's mission,
its technology and available applications for its patented and unique DNA
care ingredient called AC-11(R). Unlike the earlier site, the new site is
largely science-driven, providing direct links to a number of highly
technical, peer reviewed journal articles in the fields of medicine and
biochemistry on the subject of DNA repair and the role of AC-11(R)
(formerly C-Med-100(R)).

All-natural, herbal-extracted and patented AC-11(R) is marketed by over
100 manufacturers and marketing companies in Japan, Europe, the Middle
East, the United States and Canada in a variety of anti-aging cosmetic,
dietary supplement and advanced DNA care products.

Daniel Zwiren, president and CEO of Optigenex Inc. said, "The company is
pleased with its new home page and with the positive industry response it
has received so far. We have tried to capture on our site some of the more
recent advances in the understanding of DNA in the aging process. As the
public's awareness of and interest in the science of healthy aging
heightens, we look forward to expanding the page in the near future to
provide larger forum for discussion of this vital topic as well as an
excellent showcase for our unique technology."

About Optigenex Inc.:

Optigenex Inc. (www.optigenex.com) is a formulator, distributor and
provider of proprietary next generation skin care, supplements and bulk
ingredient featuring AC-11(R) (formerly known as C-MED-100(R)), a patented
compound, as its core technology. AC-11(R) is the bioactive,
water-soluble form of the medicinal herb Uncaria tomentosa.

*The statements made in this press release have not been evaluated by the
Food and Drug Administration. The products mentioned in this release are
not intended to diagnose, treat, cure or prevent any disease.

For more information:
Optigenex Inc.
dzwiren@optigenex.com

Copyright 2009, Market Wire, All rights reserved.

-0-